Function of Cortactin/N-cadherin signal axis in pathological myocardial hypertrophy
- Author:
Yue-Mei WANG
1
;
Wen-Jing YU
1
;
Xi-Meng SUN
1
;
Jing ZHANG
1
;
Jing LU
1
;
Pei-Qing LIU
1
Author Information
- Publication Type:Journal Article
- Keywords: cardiac hypertrophy; cardiomyocytes; cell junction; Cortaetin; isoprenaline; N-cadherin
- From: Chinese Pharmacological Bulletin 2024;40(2):234-242
- CountryChina
- Language:Chinese
- Abstract: Aim To investigate the regulatory effect of Cortaetin on pathological myocardial hypertrophy induced by isoprenaline (ISO) and the underlying mechanism. Methods ISO was used to stimulate neonatal rat cardiomyocytes for 24 h, and myocardial hypertrophy model was established at the cellular level. C57BL/6 mice were injected subcutaneously with ISO for one week to establish myocardial hypertrophy model at animal level. RT-qPCR was used to detect the changes of mRNA and Western blot was used to detect the changes of relative protein content. Immunofluorescence was used to measure the subcellular location of Cortaetin and the change of its expression. The overex-pression of Cortaetin by adenovirus infection and the knockdown of Cortaetin by transfection of small interfering RNA were studied. Results On the cellular and animal levels, ISO-induced myocardial hypertrophy models were successfully established, and it was observed that ISO caused the decrease of Cortaetin and N-cadherin protein levels. Overexpression of Cortaetin could reverse the decrease of N-cadherin protein level and myocardial hypertrophy caused by ISO. Knockdown of Cortaetin showed the opposite effect. Conclusion Cortaetin, in combination with N-cadherin, may play a role in combating myocardial hypertrophy by enhancing the connections between cardiomyocytes.
